Xeris Pharmaceuticals, Inc. SBIR Phase I Award, September 2015
A SBIR Phase I contract was awarded to Xeris Pharmaceuticals, Inc. in September, 2015 for $514,129.0 USD from the U.S. Department of Health & Human Services.
Currently, there are no issues on this topic.
Find more entities like Xeris Pharmaceuticals, Inc. SBIR Phase I Award, September 2015
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
